IBDEI1T7 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28886,1,4,0)
 ;;=4^Z91.130
 ;;^UTILITY(U,$J,358.3,28886,2)
 ;;=^5063614
 ;;^UTILITY(U,$J,358.3,28887,0)
 ;;=Z91.138^^115^1425^16
 ;;^UTILITY(U,$J,358.3,28887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28887,1,3,0)
 ;;=3^Unintented Underdosing,Other Reasons
 ;;^UTILITY(U,$J,358.3,28887,1,4,0)
 ;;=4^Z91.138
 ;;^UTILITY(U,$J,358.3,28887,2)
 ;;=^5063615
 ;;^UTILITY(U,$J,358.3,28888,0)
 ;;=T38.3X6A^^115^1425^3
 ;;^UTILITY(U,$J,358.3,28888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28888,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Init Encntr
 ;;^UTILITY(U,$J,358.3,28888,1,4,0)
 ;;=4^T38.3X6A
 ;;^UTILITY(U,$J,358.3,28888,2)
 ;;=^5049649
 ;;^UTILITY(U,$J,358.3,28889,0)
 ;;=T38.3X6S^^115^1425^4
 ;;^UTILITY(U,$J,358.3,28889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28889,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sequela
 ;;^UTILITY(U,$J,358.3,28889,1,4,0)
 ;;=4^T38.3X6S
 ;;^UTILITY(U,$J,358.3,28889,2)
 ;;=^5049651
 ;;^UTILITY(U,$J,358.3,28890,0)
 ;;=T38.3X6D^^115^1425^5
 ;;^UTILITY(U,$J,358.3,28890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28890,1,3,0)
 ;;=3^Underdosing Insulin/Oral Hypoglycemic Drugs,Sub Encntr
 ;;^UTILITY(U,$J,358.3,28890,1,4,0)
 ;;=4^T38.3X6D
 ;;^UTILITY(U,$J,358.3,28890,2)
 ;;=^5049650
 ;;^UTILITY(U,$J,358.3,28891,0)
 ;;=T46.5X6A^^115^1425^9
 ;;^UTILITY(U,$J,358.3,28891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28891,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Init Encntr
 ;;^UTILITY(U,$J,358.3,28891,1,4,0)
 ;;=4^T46.5X6A
 ;;^UTILITY(U,$J,358.3,28891,2)
 ;;=^5051353
 ;;^UTILITY(U,$J,358.3,28892,0)
 ;;=T46.5X6D^^115^1425^10
 ;;^UTILITY(U,$J,358.3,28892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28892,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Subs Encntr
 ;;^UTILITY(U,$J,358.3,28892,1,4,0)
 ;;=4^T46.5X6D
 ;;^UTILITY(U,$J,358.3,28892,2)
 ;;=^5051354
 ;;^UTILITY(U,$J,358.3,28893,0)
 ;;=T46.5X6S^^115^1425^11
 ;;^UTILITY(U,$J,358.3,28893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28893,1,3,0)
 ;;=3^Underdosing of Antihypertensive Drugs,Sequela
 ;;^UTILITY(U,$J,358.3,28893,1,4,0)
 ;;=4^T46.5X6S
 ;;^UTILITY(U,$J,358.3,28893,2)
 ;;=^5051355
 ;;^UTILITY(U,$J,358.3,28894,0)
 ;;=T43.206A^^115^1425^6
 ;;^UTILITY(U,$J,358.3,28894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28894,1,3,0)
 ;;=3^Underdosing of Antidepressants,Init Encntr
 ;;^UTILITY(U,$J,358.3,28894,1,4,0)
 ;;=4^T43.206A
 ;;^UTILITY(U,$J,358.3,28894,2)
 ;;=^5050543
 ;;^UTILITY(U,$J,358.3,28895,0)
 ;;=T43.206S^^115^1425^7
 ;;^UTILITY(U,$J,358.3,28895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28895,1,3,0)
 ;;=3^Underdosing of Antidepressants,Sequela
 ;;^UTILITY(U,$J,358.3,28895,1,4,0)
 ;;=4^T43.206S
 ;;^UTILITY(U,$J,358.3,28895,2)
 ;;=^5050545
 ;;^UTILITY(U,$J,358.3,28896,0)
 ;;=T43.206D^^115^1425^8
 ;;^UTILITY(U,$J,358.3,28896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28896,1,3,0)
 ;;=3^Underdosing of Antidepressants,Subs Encntr
 ;;^UTILITY(U,$J,358.3,28896,1,4,0)
 ;;=4^T43.206D
 ;;^UTILITY(U,$J,358.3,28896,2)
 ;;=^5050544
 ;;^UTILITY(U,$J,358.3,28897,0)
 ;;=T43.506A^^115^1425^12
 ;;^UTILITY(U,$J,358.3,28897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28897,1,3,0)
 ;;=3^Underdosing of Antipsychotics & Neuroleptics,Init Encntr
 ;;^UTILITY(U,$J,358.3,28897,1,4,0)
 ;;=4^T43.506A
 ;;^UTILITY(U,$J,358.3,28897,2)
 ;;=^5050651
 ;;^UTILITY(U,$J,358.3,28898,0)
 ;;=T43.506S^^115^1425^13
